M.J. HELO¹, I.F. AKHTIAMOV^1,2, A.M. ABDULLAH¹, F.M. SAID¹

¹Kazan State Medical University, 49 Butlerov Str., Kazan, Russian Federation, 420012

²Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan, 138 Orenburgskiy Trakt, Kazan, Russian Federation, 420064

Helo M.J. ― postgraduate student of the Department of Traumatology, Orthopedics and Surgery of Extreme States, e-mail: dr_helo_ortho@hotmail.com

Akhtiamov I.F. ― D. Sc. (medicine), Professor, Head of the Department of Traumatology, Orthopedics and Surgery of Extreme States, Chief Researcher of the Scientific Department, e-mail: Yalta60@mail.ru

Abdullah A.M. ― postgraduate student of the Department of Traumatology, Orthopedics and Surgery of Extreme States, e-mail: munnarussia@gmail.com

Said F.M. ― postgraduate student of the Department of Traumatology, Orthopedics and Surgery of Extreme States, tel. (843) 236-06-52, e-mail: Firassss86@gmail.com, ORCID ID: 0000-0002-7712-3266

 The presented literary review highlights modern views on conservative and operative methods of treatment of osteoarthritis of the knee, algorithms and features of their application. The authors consider the variants of indications and contraindications, as well as possible complications in the treatment of several stages of knee osteoarthritis, in cases of the use of treatment options, and special attention is paid to total knee replacement. The most important, from the clinical point of view, possible complications of knee replacement are analyzed and the peculiarities of arthroplasty in non-standard cases are considered. These are the development of the infection of the area of intervention, loosening of the components of the prosthesis and periprosthetic fractures. In addition, there is a risk of delay in the primary healing of the postoperative wound, nerve and vascular damage, as well as a high probability of re-intervention. The data on the treatment and management of patients with gonarthrosis, suffering from varying degrees of obesity.

Key words: osteoarthritis, conservative and operative treatment, arthroplasty, knee joint, obesity, thrombosis.

(For citation: Helo M.J., Akhtiamov I.F., Abdullah A.M., Said F.M. Treatment of arthrosis of the knee, current trends and issues. Practical Medicine. 2018)

REFERENCES

1. Alekseeva L.I., Kashevarova N.G., Taskina E.A. et al. Efficacy and safety of diacerein in patients with osteoarthritis of the knee joints. Sovremennaya revmatologiya, 2017, vol. 11, no. 3,pp. 50-57 (in Russ.). DOI: 10.14412/1996-7012-2017-3-50-57.
2. Nuzhdin V.I., Rodionova S.S., Popova T.P. Prevention of endoprosthesis instability in patients with rheumatic diseases complicated by secondary osteoporosis. Tez. konf. s mezhd. uchastiem “Problema osteoporoza v travmatologii i ortopedii”, 2000. Pp. 180-181.
3. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 2015, no. 386 (9995), pp. 743-800.
4. Naumov A.V., Khovasova N.O. To the question of clinical recommendations on osteoarthritis: why different countries have different strategies? RMZH, 2017, no. 24, pp. 1805-1811 (in Russ.).
5. Qin J., Barbour K.E., Murphy L.B. et al. Lifetime risk of symptomatic hand osteoarthritis: The Johnston County Osteoarthritis Project. Arthritis Rheumatol, 2017, no. 69 (6), pp. 1204-1212.
6. Esʹkin H.A., Atabekova JI.A., Burkov S.G. Ultrasonography of the knee joints. Ultrasound Anatomy Technique. Sono Ase-International, 2002, no. 10, pp. 85-92 (in Russ.).
7. Bukina I.E. Sinovit i kisty Beykera na rannikh stadiyakh roHapTpo3a. Consilium Medicum, 2003, no. 5 (2), pp. 96-97 (in Russ.).
8. Kolesnikov M.A., Klyushkina Yu.A., Akhtyamov I.F. The role of ultrasonography in the choice of treatment for gonarthrosis of different stages. Prakticheskaya meditsina, 2011, no. 7, 55, pp. 180-183 (in Russ.).
9. Snibbe J.C., Gambardella R.A. Treatment options for osteoarthritis. Orthopedics, 2005, no. 28 (suppl), pp. 215-20.
10. Alekseeva L.I., Zaytseva E.M. Clinical approaches to the treatment of osteoarthritis. Russkiy meditsinskiy zhurnal, 2006, vol. 14, no. 6 (258), pp. 450-453 (in Russ.).
11. Binning A. Nimesulide in the treatment of postoperative pain: a double-blind, comparative study in patients undergoing arthroscopic knee surgery. Clin. J. Pain, 2007, no. 23 (7), pp. 565-570.
12. Rawal N., Nielsen K.C., Klein S.M., McGraw Hill. Ambulatory wound and intra-articular infusions. In Ambulatory Anesthesia Perioperative Anesthesia, 2015,pp. 503-517.
13. Katorkin S.E., Bystrov S.A., Bezborodov A.I. et al. Comparative analysis of the effectiveness of selective cyclooxygenase-2 inhibitors in ambulatory surgical patients. RMZH, 2017, no. 28, pp. 2053-2056 (in Russ.).
14. Cheng K.H., Chu C.S., Lee K.T. et al. Osteoarthritis is an independent risk factor for major adverse cardiovascular events-nationwide case-control studies. European Heart Journal, 2013, no. 34, suppl. 1, p. 5173.
15. Arden N.K. et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage, 2014, no. 22 (3), pp. 363-388.
16. Breivik H., Collett B., Ventafridda V. et al. Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. Eur. J. Pain (London, England), 2006, no. 10, pp. 287-333.
17. Ripamonti C.I. et al. Management of cancer pain: ESMO Clinical Practice Guidelines. Annals of Oncology, 2011, no. 22 (Suppl. 6), pp. 69-77.
18. Wengström Y. et al. European Oncology Nursing Society breakthrough cancer pain guidelines. Eur. J. Oncol. Nurs, 2014, Apr, no.18 (2), pp. 127-31.
19. Evtushenko I.A., Marusnichenko V.V. Adjuvant therapy for chronic pain syndrome (scientific review). Mezhdunarodnyy nevrologicheskiy zhurnal, 2016, no. 3 (81), pp. 71-75 (in Russ.).
20. Markov P.V., Palʹshin G.A., Komissarov A.N. Efficiency of analgesic therapy after hip and knee joints endoprosthetics. Vestnik travmatologii i ortopedii imeni N.N. Priorova, 2014, no.1, pp. 57-60 (in Russ.).
21. Kornilov N.N., Kulyaba T.A. Ehndoprotezirovanie kolennogo sustava [Knee Endoprosthetics]. Ortopediya: natsionalʹnoe rukovodstvo. Moscow: GEHOTAR-Media, 2008. Part 7. Pp. 235-251.
22. Clegg D.O., Reda D.J., Harris C.L. et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N. Engl. J. Med, 2006, no. 354 (8),pp. 795-808.
23. Hochberg M.C., Martel-Pelletier J., Monfort J., et al. MOVES Investigation Group. Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib. Ann. Rheum. Dis., 2016, Jan, no. 75 (1), pp. 37-44.
24. Naumov A.V., Khovasova N.O. To the question of clinical recommendations on osteoarthritis: why different countries have different strategies? RMZH, 2017, no. 24, pp. 1805-1811 (in Russ.).
25. José António Pereira da Silva, Ramiro S., Pedro S., et al. Patients- and physicians-priorities for improvement. The case of rheumatic diseases, 2010, no. 35, pp. 192-199.
26. Bannuru R.R., Natov N.S., Dasi U.R. et al. Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis ― meta-analysis. Osteoarthritis Cartilage, 2011, Jun, no.19 (6), pp. 611-9. doi: 10.1016/j.joca.2010.09.014. Epub 2011, Apr 9.
27. Altman R.D., Moskowitz R. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. J. Rheumatol., 1998, no. 25 (11), pp. 2203-12.
28. Raynauld J.P., Olszynski W.P., Goldsmith C.H. et al. Effectiveness and safety of hylan G-F 20 compared to steroid injections in patients with knee arthritis (abstract). Arthritis Rheum, 2003, no. 48,p. 484.
29. Blaine T., Moskowitz R., Udell J. et al. Treatment of persistent shoulder pain with sodium hyaluronate: a randomized, controlled trial. A multicenter study. J. Bone Joint Surg. Am., 2008, vol. 90, no. 5,pp. 970-979.
30. Conrozier T., Bertin P., Mathieu P. et al. Intra-articular injections of hylan G-F 20 in patients with symptomatic hip osteoarthritis: an open-label, multicentre, pilot study. Clin. Exp. Rheumatol, 2003, vol. 21, no. 5,pp. 605-610.
31. Reichenbach S., Blank S., Rutjes A.W. et al. Arthritis Rheum, 2007, vol. 57, no. 8, p. 1410.
32. Kornilov N.V., Eropkina E.M., Eropkin M.Yu. et al. Possible ways to correct the toxic effect of acrylic bone cement using cytoprotective drugs. Travmatol. i ortoped. Rossii, 2002, no. 1, pp. 50-56 (in Russ.).
33. Lila A.M. Modern pharmacotherapy of osteoarthritis. Terramedica, 2005, no. 1 (37), pp. 3-9 (in Russ.).
34. Block J.A., Oegema T.R., Sandy J.D., Plaas A. The effects of oral glucosamine on joint health: is a change in research approach needed? Osteoarthritis Cartilage, 2010, no. 18, pp. 5-11.
35. Jenkins K., Chung F., Wennberg R. et al. Fat embolism syndrome and elective knee arthroplasty. Can. J. Anesth, 2002, no. 49,pp. 19-24.
36. Kearon S. Natural History of Venous Thromboembolism I I Natural History of VTE, 2003, pp. 1-30.
37. Cohen A.T. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet, 2008, no. 371, pp. 387-394.
38. Minasov T.B., Minasov B.Sh., Zagidullin Sh.Z. et al. Dabigatran, a new approach to the prevention of thromboembolic complications. Travmatologiya i ortopediya Rossii, 2011, no. 3, pp. 80-83 (in Russ.). DOI:10.21823/2311-2905-2011-0-3-80-83.
39. Kopenkin S.S., Skoroglyadov A.B. Problems of prevention of venous thromboembolic complications in endoprosthetics of large joints. Vestnik travmatologii i ortopedii im. H.H. Priorova, 2009, no. 3, pp. 56-58 (in Russ.).
40. Badimon L., Vilahur G. Atherosclerosis and thrombosis. The ESC Textbook of intensive and acute cardiovascular care. 2nd ed. OXFORD University press, 2015. Pp. 348-355.
41. Bozhkova S.A. Modern principles of diagnosis and antibacterial therapy of infection of prosthetic joints (literature review). Travmatologiya i ortopediya Rossii, 2011, no. 3, pp. 126-136 (in Russ.). DOI:10.21823/2311-2905-2011-0-3-126-136.
42. Akhtyamov I.F., Ziatdinov B.G., Kilʹmetov T.A., Garifullov G.G. Efficiency of electroneurostimulation as a method of preventing thromboembolic complications in hip arthroplasty. Prakticheskaya meditsina, 2017, no. 8 (109), pp. 29-36 (in Russ.).
43. Kornilov N.N., Kulyaba T.A., Novoselov K.A., Kazemirskiy A.V. et al. Features of the revision arthroplasty of the knee joint after an isolated replacement of its internal division. Travmatologiya i ortopediya Rossii, 2006, no. 2, pp. 162-162 (in Russ.).
44. Kornilov N.N., Kulyaba T.A., Novoselov K.A. Ehndoprotezirovanie kolennogo sustava [Knee arthroplasty]. Saint Petersburg: Gippokrat, 2006, 176 p.
45. Zasulʹskiy D. Yu., Pechinskiy A.I., Kulyaba T.A., Suvchuk A.V. et al. Replacement of post-resection defects of the knee joint in case of organ-sparing surgical treatment of its tumor lesions. Travmatologiya i ortopediya Rossii, 2008, vol. 2, no. 48, pp. 115-121 (in Russ.).
46. Arabmotlagh M., Rittmeister M., Hennigs T. Alendronate prevents femoral periprosthetic bone loss following total hip arthroplasty: prospective randomized double-blind study. J. Orthop. Res., 2006, Jul, no. 24 (7), pp. 1336-41. doi: 10.1002/jor.20162.
47. Lachiewicz P.F., McCaskill B., Inglis A. et al. Total hip arthroplasty in juvenile rheumatoid arthritis. Two to eleven-year results. J. Bone Joint Surg,1986, no. 68-A,pp. 502-508.
48. Kulyaba T.A., Kornilov N.N., Tikhilov P.M. et al. Treatment of paraprosthetic infection after knee joint endoprosthesis replacement (theses). Travmatologiya i ortopediya Rossii, 2008, no. 3 (suppl.), p. 51 (in Russ.).
49. Jamsen E., Nevalainen P., Eskelinen A. et al. Obesity, diabetes, and preoperative hyperglycemia as predictors of peripros-thetic joint infection a single-center analysis of 7181 primary hip and knee replacements for osteoarthritis. J. Bone Joint. Surg, 2012, vol. 94-A, no. 14,pp. e101 (1)-e101 (9).
50. Malinzak R.A., Ritter M.A., Berend M.E., Meding J.B. et al. Morbidly obese, diabetic, younger, and unilateral joint arthroplasty patients have elevated total joint arthroplasty infection rates. J. Arthroplasty, 2009, Sep, no. 24, 6 suppl, pp. 84-8. Epub. 2009, Jul. 15.
51. Kulyaba T.A., Kornilov N.N., Tikhilov P.M. et al. Srednesrochnye rezulʹtaty revizionnogo ehndoprotezirovaniya kolei sustava [Medium-term results of joint rupture endoprosthetics]. Mater. Vseros. konf. “Ehndoprotezirovanie krupnykh sustavov”, 2009. Vol. 1. P. 72.
52. Mcelroy M.J., Pivec R., Issa K. et al. The effects of obesity and morbid obesity on outcomes in TKA. J. Knee Surg, 2013, no. 26 (2), pp. 83-88. DOI: 10.1055/s-0033-1341407.
53. Prikhodʹko V.S., Tarbushkin A.A., Prokhorova M.Yu. et al. Risks in endoprosthesis replacement of large joints in patients with obesity. Ozhirenie i metabolizm, 2015, no. 12 (4), pp. 52-56 (in Russ.).
54. Kulyaba T.A., Kornilov H.N., Novoselov K.A. Risk factors for the development of infectious complications in knee arthroplasty. Travmatologiya i ortopediya Rossii, 2006, no. 2, pp. 178-179 (in Russ.).
55. Novoselov K.A., Kornilov N.N., Kulyaba T.A. Povrezhdeniya i zabolevaniya kolennogo sustava [Injuries and diseases of the knee joint]. Travmatologiya i ortopediya: pod red. N.V.Kornilova. Saint Petersburg: Gippokrat, 2006. Vol. 3. Pp. 213- 438.